BOSTON, MA--(Marketwire - March 10, 2009) - PHT Corporation is celebrating its most successful fourth fiscal quarter and year since the company’s founding in 1994. PHT is the global leader in ePRO solutions, with products and services used in more than 390 clinical trials involving hundreds of thousands patients worldwide.
Total new business bookings for fiscal Q4 increased by 68% over the previous year representing the strongest Q4 financial results in the company’s history. In the fourth quarter, the company closed 11 major new studies from six existing clients and one new account.
Phil Lee, PHT President and CEO, said, “We are pleased that in 2008 so many of our existing clients decided to entrust PHT with more of their ePRO studies. Despite the difficult global economic environment, we anticipate a strong 2009 as current clients and new sponsors turn to PHT to conduct the safest, most efficient and economical clinical trials possible.”
2008 represented the 6th consecutive year of revenue growth for PHT as the company continues to focus on effectively scaling operations and delivering the highest value ePRO solutions to its customers. As sponsors are pressed to show greater returns for each dollar invested in R&D, eClinical solutions like PHT’s LogPad Product Suite help by reducing unnecessary costs associated with error prone and time consuming paper diaries. ePRO provides faster time to analysis from database lock, adaptive trial capabilities, real-time safety monitoring between visits and less data variance for smaller, faster clinical trials that are less expensive to run. Like other eClinical technologies, ePRO is rapidly becoming an important part of an overall clinical operations efficiency strategy.
Key 2008 business highlights for PHT:
-- Innovative new Windows-based ePRO product launched -- PHT introduced its revolutionary SitePad™ Tablet, a breakthrough eSource technology, in answer to intense market demand for trustworthy site-based PRO data.
-- Expanded Strategic partnerships -- PHT established several partnerships to further the use of ePRO on a global basis. ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, now provides PHT’s LogPad® and SitePad™ Tablet to its clients. PHT also joined Medidata Solutions’ online developer community to foster collaborative innovation.
-- Oracle Enterprise Resource Planning (ERP) System Implementation -- PHT undertook a major upgrade to implement the Oracle ERP System which is integrated throughout PHT’s enterprise. The new ERP system offers customers significant business benefits including up-to-date inventory management reports and more efficient shipping and faster billing reconciliation.
-- ISO 9001:2000 Certification -- PHT is the only handheld ePRO provider to achieve this quality certification which reduces risk for sponsors. The company has maintained the world-class standard for the past six years with two re-certifications. PHT’s ISO certification makes sponsors confident to select PHT for clinical trials: every PHT employee follows best practices in all phases of the product and project delivery cycle.
-- CDISC Certification -- PHT’s StudyWorks™, an online portal for viewing and managing LogPad and SitePad data achieved CDISC certification for the Operational Data Model standard for data export enabling real-time data integration with EDC vendors and other eClinical providers.
-- New and Expanded U.S. Offices -- PHT moved to attractive new office space and increased the size of its U.S. headquarters by 54 percent.
-- Well-attended Annual User Conference -- PHT welcomed pharmaceutical and biotechnology industry thought leaders to discuss topics such as PRO regulatory updates, validation, integrity of electronic records and optimized trial designs. Clients in attendance included Acambis, Bayer HealthCare Pharmaceuticals, Bristol-Meyers Squibb, Capnia, Genentech, GlaxoSmithKline, Quintiles, Sucampo Pharmaceuticals and Wyeth.
-- PHT Executive Thought Leadership -- PharmaVOICE magazine named PHT’s European General Manager, Dr. Valdo Arnera, as one of the 100 most inspiring people in life sciences.
About PHT Corporation
Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 390 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, transmitted over reliable analog and wireless global technologies, sponsors are able to run smaller and more conclusive clinical research programs. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact:
Brenda Nashawaty
Email Contact
617-688-3253
